Kamada Ltd (KMDA) stock

KMDANasdaqPharmaceutical PreparationsFiscal year ends December 31

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 20-F on Mar 11, 2026Score 5/30

$8.09−0.04 (-0.49%)

Close on Nov 13, 2026Market cap $466.68MP/E –Yield –

Kamada gross margin

Gross margin is gross profit as a percentage of revenue.

Kamada's gross margin for the twelve months ending Jun 30, 2026 was 40.8%. For fiscal 2025 it was 42.3%, against 43.5% the year before. The highest annual figure on record is 43.5% in fiscal 2024.

Annual gross margin

Period	Period end	Value	Change (pts)
FY2025	Dec 31, 2025	42.3%	−1.1
FY2024	Dec 31, 2024	43.5%	+4.5
FY2023	Dec 31, 2023	38.9%	+2.8
FY2022	Dec 31, 2022	36.1%	+6.8
FY2021	Dec 31, 2021	29.3%	−6.4
FY2020	Dec 31, 2020	35.7%	−3.4
FY2019	Dec 31, 2019	39.1%	+2.9
FY2018	Dec 31, 2018	36.2%	+5.0
FY2017	Dec 31, 2017	31.2%	+3.6
FY2016	Dec 31, 2016	27.6%	+5.6
FY2015	Dec 31, 2015	22.0%	–

Quarterly gross margin

Change is against the same quarter a year earlier.

Period	Period end	Value	Change (pts)
Q2 FY2026	Jun 30, 2026	40.9%	−1.4
Q1 FY2026	Mar 31, 2026	42.3%	−4.9
Q4 FY2025	Dec 31, 2025	38.0%	−5.7
Q3 FY2025	Sep 30, 2025	42.0%	+0.7
Q2 FY2025	Jun 30, 2025	42.3%	−2.3
Q1 FY2025	Mar 31, 2025	47.1%	+2.7
Q4 FY2024	Dec 31, 2024	43.7%	+4.1
Q3 FY2024	Sep 30, 2024	41.3%	+2.3
Q2 FY2024	Jun 30, 2024	44.6%	+6.1
Q1 FY2024	Mar 31, 2024	44.4%	+5.8
Q4 FY2023	Dec 31, 2023	39.6%	+3.5
Q3 FY2023	Sep 30, 2023	39.0%	−0.9
Q2 FY2023	Jun 30, 2023	38.6%	+7.9
Q1 FY2023	Mar 31, 2023	38.6%	−1.7
Q4 FY2022	Dec 31, 2022	36.1%	+15.2
Q3 FY2022	Sep 30, 2022	39.9%	+15.1
Q2 FY2022	Jun 30, 2022	30.7%	−6.7
Q1 FY2022	Mar 31, 2022	40.2%	+8.0
Q4 FY2021	Dec 31, 2021	21.0%	−21.0
Q3 FY2021	Sep 30, 2021	24.9%	–
Q2 FY2021	Jun 30, 2021	37.4%	–
Q4 FY2020	Dec 31, 2020	32.2%	–
Q3 FY2020	Sep 30, 2020	42.0%	–